The FDA has authorized Merck's COVID pill for home use — the second in two days
The medicine, called molnupiravir, is taken twice a day for five days and works by preventing the virus from replicating. Merck says it will have 10 million packs available by the end of the month.
by Scott Hensley
Dec 23, 2021
1 minute
The U.S. Food and Drug Administration has authorized the second antiviral pill to treat COVID-19 at home.
The medicine, called molnupiravir and made by Merck and Ridgeback Biotherapeutics, is taken twice a day for
You’re reading a preview, subscribe to read more.
Start your free 30 days